Wave 1 CCGs get green light

The NHS Commissioning Board has authorised the first wave of CCGs to take control of the NHS budget to fund healthcare services for their communities.

UK launches genetic database for drug discovery

The NHS will build a database of 100,000 human genomes to assist the development of new therapies for cancer and rare genetic diseases.

QIPP versus NICE – the war goes on

QIPP is trumping NICE as the driver of local prescribing decisions, with price ranked above value, the parliamentary Health Select Committee has been told.

Austerity is damaging care, says CQC

The quality of care in England’s hospitals and nursing homes is suffering due to poor staffing levels and pressure on resources.

Commissioners set for NHS ‘demolition’

CCG leaders must become “demolition experts”, dismantling old services and commissioning new ones, the Chairman of the NHS Alliance has said.

Liver disease is a public health priority

Urgent action by public health authorities is needed to address the rising prevalence of liver disease in England, the Chief Medical Officer has said.

Easton: Private challenge ‘too good to miss’

Jim Easton has formally stepped down from his role as National Director: Transformation at the NHS Commissioning Board and National Director for Improvement and Efficiency at the DH.

NHS CB gets £1.8bn for public health commissioning

The NHS Commissioning Board (NHS CB) has been given £1.8bn to commission certain public health services by the Department of Health as part of a new agreement.

Trusts launch medicines waste campaign

A host of NHS trusts across south east London have launched a new medicines management campaign to combat widespread drug waste and treatments being misused or taken incorrectly.

Hunt aims for global telehealth domination

A new telehealth scheme has been launched by the DH to help an initial 100,000 patients with long-term conditions gain control over their own care.

Latest articles

Novartis releases new data on Cosentyx

Novartis release new data on Cosentyx ® for psoriatic arthritis

Novartis releases new data on Cosentyx ® (secukinumab) from two trials of psoriatic arthritis (PsA) patients.   PsA is a complex disease with multiple manifestations driving...
Mundipharma announces exclusive distribution agreement for Pelmeg in Central and Eastern Europe

Mundipharma announces exclusive distribution agreement for Pelmeg▼®

Mundipharma announces exclusive distribution agreement for Pelmeg in Central and Eastern Europe. Mundipharma has entered into the exclusive distribution agreement with Egis Pharmaceuticals for Pelmeg,...
Medicines Discovery Catapult and Waters Corporation enter strategic partnership for access to brand-new mass spectrometry technologies.

Medicines Discovery Catapult and Waters Corporation enter strategic partnership

Medicines Discovery Catapult and Waters Corporation enter strategic partnership. The partnership will give small and medium enterprises (SMEs) working with Medicines Discovery Catapult unprecedented access to...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Mundipharma announces exclusive distribution agreement for Pelmeg in Central and Eastern Europe

Mundipharma announces exclusive distribution agreement for Pelmeg▼®

Mundipharma announces exclusive distribution agreement for Pelmeg in Central and Eastern Europe. Mundipharma has entered into the exclusive distribution agreement with Egis Pharmaceuticals for Pelmeg,...
new migraine data for Aimovig presented by Novartis

Novartis presents new migraine data for Aimovig®▼ (erenumab)

Novartis presents new migraine data for Aimovig®▼ (erenumab) demonstrating sustained efficacy to 52 weeks. Novartis has announced that new data from two follow-up studies of...
many different cartoon faces depicting understanding clinical commissioning and its changing faces

Understanding clinical commissioning: policies, systems and legislation

Sara Bainbridge gives an understanding of clinical commissioning and explores its changing face through new policies, systems and legislation. For anyone involved with the NHS...
man rowing the tip of an iceberg: 2D matrix coding achieve for the pharma industry

What will 2D matrix coding achieve for the pharma industry?

Tony Cordrey is Vice President of European Strategic Operations at Accord Healthcare. Having been at the forefront of the Falsified Medicines Directive (FMD) rollout,...